Pilar Nieva-Lopez

Madrid, MD 28049, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

Journal: International journal of molecular sciences
Published: May 19, 2023

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.

Journal: British journal of haematology
Published: March 19, 2023

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.

Journal: British journal of haematology
Published: December 29, 2022

Patterns of Differentially Expressed circRNAs in Human Thymocytes.

Patterns of Differentially Expressed circRNAs in Human Thymocytes.

Journal: Non-coding RNA
Published: February 25, 2022

Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime.

Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime.

Journal: Scientific reports
Published: November 08, 2021

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.

Journal: BMC cancer
Published: June 13, 2019

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells.

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells.

Journal: Carcinogenesis
Published: May 17, 2019

More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.

More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.

Journal: The oncologist
Published: November 23, 2018

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Journal: Oncogene
Published: July 06, 2018

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.

Journal: Scientific reports
Published: July 03, 2018

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.

Journal: BMC cancer
Published: June 26, 2017

Transcriptomic analysis reveals sex-specific differences in the expression of Dcl1 and Fis1 genes in the radio-adaptive response of thymocytes to TRP53-mediated apoptosis.

Transcriptomic analysis reveals sex-specific differences in the expression of Dcl1 and Fis1 genes in the radio-adaptive response of thymocytes to TRP53-mediated apoptosis.

Journal: BMC genomics
Published: August 07, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026